Listen on the go
CORRECT!
Next question
touchCARDIO touchCARDIO
    • FILTER YOUR SEARCH
    Content Type:
    Speciality:
    More Specialities
    Conference:
    More Conferences

    • Hypertension

    World Partner

    US Partner

    An Introduction to Hypertension

    Hypertension is one of the most significant risk factors for morbidity and mortality worldwide and is responsible for the deaths of approximately 9million people each year. Despite the availability of effective treatments, many people remain with high blood pressure that is not under optimal control. Advancing technologies are likely to play an important role in improving screening, detection and control of hypertension over the next few years.

    Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer-reviewed articles from our journal portfolio.

    Our supporting partners do not constitute an endorsement of the content on this page.

    Hypertension Content

    Arrhythmia, Atherosclerosis, Atrial Fibrillation, Cardiovascular Disease, Congenital Conditions, COVID-19, Electrophysiology, Heart Failure, Hypertension, Imaging, Interventional Cardiology, Stroke, Thrombosis
    Heart International achieves new Impact Factor milestone of 1.9 in 2024 Journal Citation Reports

    touchCARDIO is delighted to announce that Heart International has received an impressive new Impact Factor of 1.9 in the 2024 Journal Citation Reports (JCR). This achievement marks a notable increase from last year’s Impact Factor of 0.2 and highlights the journal’s growing influence in the cardiology field.

    Hypertension
    Watch Time: 34 mins
    touchIN CONVERSATION
    Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment
    CE/CME ACCREDITED Prof. Jean-Luc Vachiéry, Prof. Manreet Kanwar Translations available:

    Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.

    Learning objectives
    Learning Objectives
    • Outline the clinical features of PAH and the steps to diagnosis
    • Recognize the importance of risk stratification of patients with PAH to optimize treatment management
    • Apply current guideline-recommended treatment algorithms and emerging therapeutic agents for PAH
    Hypertension
    Dietary acid reduction with fruits and vegetables shows superior cardiovascular benefits in hypertensive patients with chronic kidney disease

    A recent study published in The American Journal of Medicine reported the benefits of high fruit and vegetable diets and oral sodium bicarbonate (NaHCO3) for managing hypertension-related chronic kidney disease (CKD) and cardiovascular disease

    Arrhythmia, Cardiovascular Disease, Heart Failure, Hypertension
    ESC 2024 preview: Personalising cardiovascular care

    The ESC Congress is a key event in our conference calendar, and this year, London will welcome thousands of cardiologists and allied healthcare professionals. Together, they will work to transform patient care and advance the field through cutting-edge research, pioneering technologies, and collaborative initiatives.

    Hypertension
    Renal Denervation for Hypertension: The Current Landscape and Future Directions
    Brian Fulton, Jay Giri, Florian Rader

    Heart International. 2024;18(1):5-8

    Hypertension (HTN) is one of the largest contributors to cardiovascular (CV) morbidity and mortality in the USA and is estimated to affect 47% of the adult population or approximately 122 million adults older than 20 years of age.1 Recent estimates suggest that over 40% of these patients continue to have uncontrolled blood pressure (BP) and that […]

    Hypertension
    Watch Time: 33 mins
    touchEXPERT OPINIONS
    Improving outcomes in pulmonary arterial hypertension: A multidisciplinary approach
    CE/CME ACCREDITED Prof. Harrison Farber, Prof. Marion Delcroix, Prof. Stephan Rosenkranz

    Watch three experts share their perspectives and best-practice guidance on how to optimize the diagnosis and management of pulmonary arterial hypertension (PAH).

    Learning objectives
    Learning Objectives
    • Recognize the importance of early diagnosis and rapid classification of PAH
    • Discuss the setting of effective treatment goals and implementing appropriate therapeutic strategies
    • Evaluate the data for emerging therapies and strategies for improving quality of life for patients with PAH
    Hypertension
    Developed by Touch
    Kelly Chin, ACC 2023: The treatment paradigm for patients with pulmonary arterial hypertension
    Watch Time: 1 min

    Recommended therapy for patients with pulmonary arterial hypertension is generally a combination of an endothelin receptor antagonist and a phosphodiesterase type 5 inhibitor. In this touchCARDIO interview, we speak with Dr Kelly Chin (UT Southwestern Medical Centre, Dallas, TX, USA) to discuss the treatment paradigm. Dr Chin presented an abstract entitled ‘Efficacy And Safety Of […]

    Hypertension
    Developed by Touch
    Kelly Chin, ACC 2023: A DUE phase III study, a macitentan and tadalafil combination for patients with pulmonary arterial hypertension
    Watch Time: 4 mins

    The aim of the A DUE study was to assess the combination of macitentan and tadalafil for patients with pulmonary arterial hypertension. In this touchCARDIO interview, we speak with Dr Kelly Chin (UT Southwestern Medical Centre, Dallas, TX, USA) to discuss the findings of the trial and the clinical impact.  The abstract entitled ‘Efficacy And […]

    Hypertension
    Developed by Touch
    Marius Hoeper, ACC 2023: STELLAR phase III trial results – Sotatercept for the treatment of pulmonary arterial hypertension
    Watch Time: 6 mins

    Pulmonary arterial hypertension (PAH) is a progressive disease involving proliferative remodeling of the pulmonary vessels and elevations in pulmonary vascular resistance (PVR). Despite recent treatment advances, the associated morbidity and mortality rates of the disease are still high. In this touchCARDIO interview, we speak with Prof. Marius Hoeper (Department of Respiratory Medicine, Hannover Medical School, Hannover, […]

    In Partnership with...
    Useful Links:
    About us Society Partners Press Releases Contact Us Permissions Terms & Conditions Privacy Policy Cookie Preferences
    Connect With Us:

    Other websites from Touch Medical Media:

    touchONCOLOGY
    touchOPHTHALMOLOGY
    touchENDOCRINOLOGY
    touchNEUROLOGY
    touchCARDIO
    touchRESPIRATORY
    touchIMMUNOLOGY
    touchINFECTIOUS DISEASES
    touchHAEMATOLOGY
    touchDERMATOLOGY

    Copyright® 2024 Touch Medical Media. Touch Medical Media Group Holdings Limited, a private limited company registered in England and Wales at 3 Stockport Exchange | Stockport | Cheshire | SK1 3GG | UK with registered number 08197142.

    touchCARDIO is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.

    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
    Close Popup